Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary Dipaolo

Sports Medicine Florence, SC Medical Doctor

NPI 1265873194 CMS profile 1252706

1005 E Cheves St, Florence, SC 29506

Open in the dashboard

General payments

$34,542

166 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zachary Dipaolo of Florence, SC is reported in the CMS Open Payments database as having received $34,542 across 166 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,582 15
2024 General $231 4
2023 General $3,109 33
2022 General $5,725 27
2021 General $5,074 27
2020 General $3,473 11
2019 General $15,348 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Dipaolo
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Zachary Dipaolo were reported at $1,582. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Zachary Dipaolo Sports Medicine median Middle half National median
2019 $15,348 $1,176 $199–$4,249 $163
2020 $3,473 $708 $96–$2,890 $114
2021 $5,074 $1,213 $152–$3,994 $132
2022 $5,725 $1,230 $159–$3,998 $149
2023 $3,109 $584 $146–$2,836 $160
2024 $231 $628 $163–$3,168 $164
2025 $1,582 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Peerless Surgical Inc. $15,874 58 payments
  2. Arthrex, Inc. $14,000 81 payments
  3. Smith+Nephew, Inc. $1,976 13 payments
  4. Stryker Corporation $1,478 6 payments
  5. Medical Device Business Services, Inc. $675 1 payment
  6. Zimmer Biomet Holdings, Inc. $303 2 payments
  7. Episurf Medical, Inc. $149 1 payment
  8. Vericel Corporation $49 2 payments
  9. Elite Orthopedics, LLC $20 1 payment
  10. Bioventus LLC $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $19,009 16 payments
  2. Travel and Lodging $10,113 39 payments
  3. Food and Beverage $5,420 111 payments
Products named General payments · program years 2019–2025
  1. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $1,257 3 payments
  2. FAST-FIX FLEX $1,045 6 payments
  3. Meniscal Root Repair System $962 5 payments
  4. BIOSURE REGENESORB $862 4 payments
  5. NOVOSTITCH PRO $862 4 payments
  6. ACUFEX Knee $862 4 payments
  7. FAST-FIX 360 $382 1 payment
  8. Persona $153 1 payment
  9. MyMobility $153 1 payment
  10. ROSA $153 1 payment
  11. Other $829 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

250

Median for Sports Medicine: 144

Drug cost

$1,358

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 109 $491
Celecoxib Generic 11 $309
Meloxicam Generic 60 $144
Ibuprofen Generic 12 $141
Methylprednisolone Generic 18 $119
Cyclobenzaprine Hcl Generic 22 $107
Tramadol Hcl Generic 18 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$127,051

Of which drugs: $1,632

Medicare patients

246

Average age 72

Services billed

6,792

138 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 33%
Chronic kidney disease 30%
Depression 24%
Heart failure 20%
COPD 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 53 5,640 $575
Injection, methylprednisolone acetate, 40 mg J1030 Office 25 72 $333

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

166 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record